About UMHATEM 'N.I. Pirogov', EAD
Университетска многопрофилна болница за активно лечение и спешна медицина „Николай Иванович Пирогов“, ЕАД е най-големият по рода си център за спешна медицинска помощ в България.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Baxalta now part of Shire
1
Bayer
1
Clinical Trials at UMHATEM 'N.I. Pirogov', EAD
During the past decade, UMHATEM 'N.I. Pirogov', EAD conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
2019-09-05
2027-01-31
Recruiting
900
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease
2020-01-13
2031-08-01
Recruiting
1,115
Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.
2020-06-15
2022-02-18
Completed
1,808
Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).
2021-08-25
2022-07-25
Terminated
1,411
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
2021-09-09
2022-04-12
Completed
2,954
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UMHATEM 'N.I. Pirogov', EAD"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at UMHATEM 'N.I. Pirogov', EAD
According to Clinical.Site data, the most researched conditions in "UMHATEM 'N.I. Pirogov', EAD" are
"COVID-19" (2 trials), "Acute Non-cardioembolic Ischemic Stroke" (1 trials), "Crohn's Disease" (1 trials), "Hemophilia A" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "UMHATEM 'N.I. Pirogov', EAD" in a lesser frequency.
Clinical Trials Intervention Types at UMHATEM 'N.I. Pirogov', EAD
Most popular intervention types in "UMHATEM 'N.I. Pirogov', EAD" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Etrasimod" (2 trials), "PF-07321332" (2 trials), "Placebo" (2 trials), "Ritonavir" (2 trials) and "Antihemophilic Factor (Recombinant), Porcine Sequence (BAX 802)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UMHATEM 'N.I. Pirogov', EAD
The vast majority of trials in "UMHATEM 'N.I. Pirogov', EAD" are
5 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at UMHATEM 'N.I. Pirogov', EAD
Currently, there are NaN active trials in "UMHATEM 'N.I. Pirogov', EAD".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in UMHATEM 'N.I. Pirogov', EAD,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in UMHATEM 'N.I. Pirogov', EAD, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".